Surgical mesh with protective barrier

Mesh Complications After Hernia Surgery? A Breakthrough in Adhesion Prevention

"New research explores how a combination of icodextrin and dimetindene maleate can significantly reduce post-operative adhesions and improve patient outcomes."


Ventral incisional hernias are a common issue after abdominal surgery, affecting 10% to 20% of patients. While surgical meshes have greatly improved hernia repair by reducing recurrence rates, they can cause adhesions when placed inside the peritoneum. These adhesions, abnormal connections between tissues, can lead to significant complications.

Adhesions can result in bowel obstruction, mesh infections, fistulas, and difficulties in future surgeries. Dealing with these complications is a major challenge. Researchers are constantly seeking new methods to prevent or reduce adhesion formation, improving patient outcomes and reducing the need for additional interventions.

This article explores a recent study on a combined treatment using icodextrin 4% and dimetindene maleate to prevent adhesions following the implantation of polypropylene and titanium-coated polypropylene meshes. This innovative approach could minimize the risks and improve the success of hernia repair surgeries.

AI Search Multiple angles on this topic

Mesh Repair and Fixation Limits

Incisional hernia repair frequently uses prosthetic mesh, but concern remains about adhesions forming between the mesh and surrounding tissues. Research has evaluated antiadhesive liquids and coatings as possible ways to prevent adhesion formation. Mesh fixation also remains unsettled: a February 2024 systematic review and network meta-analysis examined the advantages and disadvantages of different techniques in ventral and incisional hernia repair. In laparoscopic inguinal hernia repair, fixation is not routinely required in most cases, and when it is indicated, the optimal method remains uncertain.

How Does the Icodextrin and Dimetindene Maleate Combination Prevent Adhesions?

Surgical mesh with protective barrier

The study, published in the Journal of Surgical Research in February 2019, investigated the effectiveness of a combined treatment using icodextrin 4% and dimetindene maleate in preventing peritoneal adhesions following mesh implantation. Researchers divided sixty female white rabbits into four groups to test the treatment.

The first two groups received a lightweight polypropylene mesh, while the latter two had a titanium-coated polypropylene mesh implanted. Groups 2 and 4 were treated with intravenous dimetindene maleate and an intraperitoneal solution of icodextrin 4% during surgery, followed by intramuscular dimetindene maleate for six days post-operation.

  • Group 1: Polypropylene mesh implantation.
  • Group 2: Polypropylene mesh + intraoperative and post-operative Icodextrin 4% and dimetindene maleate.
  • Group 3: Titanium-coated polypropylene mesh.
  • Group 4: Titanium-coated polypropylene mesh + intraoperative and post-operative Icodextrin 4% and dimetindene maleate.
AI Search Multiple angles on this topic

Emerging Antiadhesion Strategies

An experimental study of starch and carboxymethylcellulose in hernia surgery with coated meshes reported adhesions affecting more than 75% of the mesh area in 2.6% of animals on the experimental side, compared with 28.9% on the control side. Research on polypropylene mesh modified with a titanium compound has also described anti-adhesion activity, with low shrinkage associated with lower adhesion and inflammatory-response rates in the cited studies. Another report notes that pretreatment with 4% icodextrin and dimetindene maleate prevented postoperative complications when polypropylene and titanium mesh were used. A 2026 meta-analysis is evaluating the safety and effectiveness of long-term absorbable biosynthetic meshes designed to provide temporary reinforcement while potentially reducing mesh-related morbidity.

Persistent Mesh Complications

Reported mesh complications range from minor discomfort to severe, life-altering conditions that may require additional surgery and long-term medical care. Commonly described problems include chronic pain, infection, mesh migration, adhesions, seroma formation, and hernia recurrence. One clinical summary estimates chronic pain in approximately 10% to 30% of patients and infection in about 1% to 8%, although these figures come from that source's report. Consumer information also identifies bowel complications, device recalls, and product-liability lawsuits as continuing concerns.

Fixation Lessons From Ankle Surgery

A study of acute unstable ankle syndesmosis rupture compared two fixation methods: a 3.5 mm quadricortical metallic screw and a suture-button device called TightRope®. The TightRope® device is identified as an Arthrex product from Naples, Florida. The study's purpose was to compare the rate of syndesmosis malreduction after surgical treatment. This comparison concerns ankle fixation rather than hernia mesh, so it does not establish which hernia-mesh fixation method is superior.

After a 15-day observation period, the researchers evaluated adhesion scores, the percentage of affected mesh surface, tissue hydroxyproline levels, and tissue histopathology to determine the treatment's effectiveness. They aimed to find out if the combination of icodextrin and dimetindene maleate could prevent adhesion formation in these animal models.

What are the Implications for Future Surgical Practices?

The findings suggest that combining icodextrin 4% and dimetindene maleate effectively reduces the extent and severity of adhesions. This combination can be a successful strategy for preventing adhesion formation after mesh implantation. Further research is needed to optimize the treatment and assess its long-term benefits, this study offers a promising step toward improving surgical outcomes and patient quality of life following hernia repair.

AI Search Multiple angles on this topic

Toward Multifunctional Mesh

A 2026 review describes hernia repair as one of the most frequently performed surgeries worldwide and identifies organ occlusion, seroma, persistent pain, tissue adhesions, and wound infection as ongoing challenges. It presents multifunctional hernia-repair mesh as part of efforts to minimize these complications. The American College of Surgeons describes mesh as a major success in biomedical engineering over the last 50 to 60 years because it has made repair durability more predictable and reliable. Emerging discussions nevertheless emphasize shared decision-making about chronic pain, infection, device complications, and possible future reoperation.

Designing Around Adhesions

Intraperitoneal adhesions are described as a major complication of abdominal repair surgeries, including hernia repair. One research team fabricated an anti-adhesive composite mesh using a macroporous monofilament polypropylene mesh and a degradable elastomer coating. The coating was designed to meet the requirements of this clinical application while remaining bioresorbable. This approach reflects a broader effort to address adhesion risk through mesh design rather than relying only on surgical technique.

Patients’ Experience of Complications

Research on minimally invasive intraperitoneal onlay mesh placement for small to medium-sized hernias notes that the approach has attracted negative attention because of perceived long-term mesh-related risks. However, the same report states that sparse data support those claims after minimally invasive repair. Separate research on patient perspectives identified themes that illuminate how people experience mesh-related complications. Those themes may help inform development of a patient-reported outcome measure assessing the true incidence of complications and their effect on quality of life.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.jss.2018.10.003, Alternate LINK

Title: Adhesion Prevention To Polypropylene Meshes Using Combined Icodextrin Four Percent And Dimetindene Maleate

Subject: Surgery

Journal: Journal of Surgical Research

Publisher: Elsevier BV

Authors: Konstantinos Bouliaris, Eftihia Asprodini, Panagiotis Liakos, Alexandros Diamantis, Georgios Koukoulis, Christina Befani, Stella Tzika, Konstantinos Tepetes

Published: 2019-02-01

Everything You Need To Know

1

What are adhesions, and why are they a concern after hernia surgery?

Adhesions are abnormal connections that can form between tissues inside the body, especially after surgical procedures like hernia repair. These connections can lead to various complications, including bowel obstruction, mesh infections, and fistulas. The placement of surgical meshes, such as polypropylene and titanium-coated polypropylene meshes, inside the peritoneum can increase the risk of these adhesions. The primary issue with adhesions is that they can cause significant problems and require additional interventions for the patient, impacting their recovery and quality of life.

2

What is the combined treatment being studied to prevent adhesions?

A recent study explored the use of a combination of icodextrin 4% and dimetindene maleate to prevent the formation of adhesions. This approach was tested on female white rabbits that underwent mesh implantation. During the surgery, some rabbits received an intraperitoneal solution of icodextrin 4% and intravenous dimetindene maleate, followed by intramuscular dimetindene maleate for six days. The study aimed to determine if this combination could reduce the extent and severity of adhesions.

3

How was the effectiveness of the combined treatment measured?

The study investigated the impact of using icodextrin 4% and dimetindene maleate after mesh implantation by evaluating several factors after a 15-day observation period. These included adhesion scores, the percentage of the mesh surface affected by adhesions, tissue hydroxyproline levels, and tissue histopathology. By analyzing these parameters, researchers could assess how effectively the combined treatment prevented adhesion formation and its overall impact on the surgical outcomes.

4

What are the potential benefits of using icodextrin 4% and dimetindene maleate?

The findings suggest that the combination of icodextrin 4% and dimetindene maleate is effective in reducing the extent and severity of adhesions following mesh implantation. This is significant because it could minimize complications such as bowel obstruction, mesh infections, and fistulas. The use of this treatment offers a promising step towards improving surgical outcomes and patient quality of life following hernia repair, potentially reducing the need for additional interventions.

5

What are the next steps in researching this adhesion prevention approach?

While the study shows promising results, further research is necessary. Optimizing the treatment protocol and assessing its long-term benefits are essential steps. Further studies may look into the long-term effects on patients, the optimal dosages, and the efficacy across various patient populations. Such future research will enhance the current understanding of adhesion prevention strategies and refine the use of icodextrin and dimetindene maleate in clinical practice to improve patient outcomes.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.